This inventor holds 1 USPTO granted patent. Top assignee: Thomas Jefferson University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Robert Devlin Carlson
Introduction
Robert Devlin Carlson is an accomplished inventor based in Sewell, NJ (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of innovative therapeutic techniques. His work focuses on enhancing cancer treatment through advanced technologies.
Latest Patents
Robert holds a patent for "Desmoglein 2-directed chimeric antigen receptor (CAR) constructs and methods of use." This patent represents a breakthrough in targeted cancer therapies, showcasing his commitment to improving patient outcomes through scientific innovation. He has 1 patent to his name.
Career Highlights
Robert is affiliated with Thomas Jefferson University, where he conducts research and collaborates with other experts in the field. His role at the university allows him to contribute to cutting-edge research and development in cancer treatment methodologies.
Collaborations
Robert has worked alongside notable colleagues, including My Georgia Mahoney and Adam E Snook. These collaborations have fostered a dynamic research environment, leading to advancements in their shared field of study.
Conclusion
Robert Devlin Carlson's contributions to biomedical engineering and cancer treatment exemplify the impact of innovative thinking in healthcare. His work continues to inspire advancements that may change the landscape of cancer therapies in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile